LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

APLLTD

NSEBSE
Alembic Pharmaceuticals Limited
Healthcare· Pharmaceuticals & Biotechnology· INE901L01018· Scrip: 533573
ENहिन्दीગુજરાતીमराठी
769.15
3.40 (+0.44%)
5/5/2026, 3:28:13 pm
NSE
769.15
3.40
+0.44%
BSE
764.90
10.40
+0.00%
6527508489461,04405-0506-3008-2610-2412-2202-1904-2805-04
244 trading days · 1Y period
TODAY
Open767.00
High775.00
Low762.90
Prev Close765.75
Volume2.38L
Value₹18.3Cr
L: 762.90H: 775.00
52 WEEK
Low635.80
High1,107.90
28% of 52W range
Info
Face Value₹2
Listed2011-09-20
ISININE901L01018
SeriesA
BSE Scrip533573

Key Metrics

1D
+1.87%
1W
+2.41%
1M
+10.80%
3M
+0.96%
6M
-17.47%
Valuation
Mkt Cap₹13277 Cr
Growth (QoQ)
Revenue+2.72%
PAT-10.09%
EPS-10.01%
Profitability
Dividend
Yield1.43%
Growth+0.00%
TTM Revenue
₹6419 Cr
TTM EBITDA
₹976 Cr
TTM PAT
₹604 Cr
TTM EPS
₹30.72
Rev/Share
₹326.6

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr423 Cr846 Cr1270 Cr1693 Cr22-1223-0323-0923-1224-0324-0624-0924-126.27.87.09.29.16.87.87.0
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-311693 Cr1525 Cr247 Cr177 Cr138 Cr7.01
2024-09-301648 Cr1498 Cr250 Cr180 Cr153 Cr7.79
2024-06-301562 Cr1407 Cr226 Cr157 Cr135 Cr6.85
2024-03-311517 Cr1337 Cr253 Cr183 Cr178 Cr9.07
2023-12-311631 Cr1449 Cr254 Cr185 Cr180 Cr9.18
2023-09-301595 Cr1470 Cr203 Cr135 Cr137 Cr6.95
2023-03-311406 Cr1283 Cr199 Cr125 Cr153 Cr7.76
2022-12-311509 Cr1341 Cr235 Cr168 Cr122 Cr6.20

Shareholding Pattern

CURRENT2026-03-31
69.7%PROMOTER
Promoter69.7%
FII4.3%
DII16.2%
Public30.3%
PROMOTER HOLDING TREND
69.6%24-0669.6%24-0969.6%24-1269.7%25-0369.7%25-0969.7%25-1269.7%26-03

Corporate Actions

Ex-DateTypePurpose
2025-07-29DividendDividend - Rs 11 Per Share
2024-07-15DividendDividend - Rs 11 Per Share
2023-07-28DividendDividend - Rs 8 Per Share
2022-08-17DividendInterim Dividend - Rs 10 Per Share
2021-07-19Dividend Annual General Meeting/Dividend - Rs 14 Per Share
2020-03-16Dividend Interim Dividend - Rs 7 Per Share Special Dividend - Rs 3 Per Share
2019-07-18Dividend Annual General Meeting/Dividend Rs 5.50/-
2018-07-18Dividend Annual General Meeting/Dividend- Rs 4 Per Share (Purpose Revised)
2017-07-11Dividend Annual General Meeting/Dividend -Rs 4/- Per Share
2016-07-20Dividend Annual General Meeting/Dividend - Rs 4/- Per Share
2015-07-22DividendAnnual General Meeting/ Dividend - Rs 3.50/- Per Share
2014-07-17DividendAnnual General Meeting / Dividend - Rs 3/- Per Share
2013-07-29DividendAnnual General Meeting And Dividend Rs.2.50 Per Share
2012-07-31DividendAnnual General Meeting / Dividend Rs 1.40 Per Share

Earnings Transcripts

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
4 Nov 2025NSE17K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
5 Aug 2025NSE15K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
6 May 2025NSE17K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
3 Feb 2025NSE17K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
7 Nov 2023NSE16K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
4 Aug 2023NSE12K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation
5 May 2023NSE14K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Revision in timings of Post Results ...
26 Apr 2023NSE3K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...
17 Nov 2022NSE32K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional I...
9 Nov 2022NSE3K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...
10 Aug 2022NSE33K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Revision in timings of Post Results ...
2 Aug 2022NSE3K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...
9 May 2022NSE45K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor ...
9 Jan 2019NSE2K chars
Read →
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 21...
21 Jan 2016NSE
Read →
Alembic Pharmaceuticals Limited has informed the Exchange that the Company will hold Post Results Co...
19 Jan 2016NSE
Read →

Price History

DateOpenHighLowCloseVolume
2026-05-04759.95770.95755.00765.753.38L
2026-04-30760.00762.00751.35755.0027,314
2026-04-29759.95769.00753.60761.1052,498
2026-04-28762.55767.70753.15759.4034,915
2026-04-27784.85795.95760.10764.601.67L
2026-04-24781.25781.25750.00751.0540,724
2026-04-23764.00784.60761.75768.7567,598
2026-04-22760.85773.15758.25764.6030,290
2026-04-21757.50767.80750.20764.3062,917
2026-04-20784.85785.00755.00757.5070,757
2026-04-17753.95797.00751.35784.752.38L
2026-04-16746.00753.65733.25748.3085,860
2026-04-15728.95741.50720.10734.8082,660
2026-04-13715.00728.20704.50717.5044,865
2026-04-10720.25736.15720.25724.2035,583
2026-04-09725.95729.65715.85720.1541,524
2026-04-08716.00748.00700.00726.251.58L
2026-04-07655.55695.00652.15690.101.35L
2026-04-02666.50673.55650.00656.2060,922
2026-04-01668.95681.45665.25677.0558,162
2026-03-27694.00694.15666.00673.557.10L
2026-03-25675.00699.00667.20694.152.71L
2026-03-24662.00678.55638.15673.201.74L
2026-03-20656.95686.95656.95677.3070,386
2026-03-19670.00671.35652.00655.4547,930
2026-03-18672.90684.00669.40676.3047,914
2026-03-17675.75682.45665.10670.0035,053
2026-03-16678.00686.90667.05675.3052,315
2026-03-13703.30704.95675.00677.9545,309
2026-03-12704.20709.65692.65703.3024,838

Frequently Asked Questions

About

Alembic Pharmaceuticals Limited, a prominent player in India's pharmaceutical sector, primarily focuses on the development, manufacturing, and marketing of generic and specialty pharmaceutical products. Known for its wide range of affordable medicines, including key formulations like Atorvastatin Calcium and Metformin Hydrochloride, the company has established itself as a significant contributor to the Indian generics industry since its inception in 1950.

Advertisement
BOARD OF DIRECTORS
Chirayu Amin
Managing Director
Pranav Amin
Managing Director
Shaunak Amin
Managing Director
Archana Hingorani
Independent Director
DEPARTED
Ashok Barat
Independent Director
Geeta Goradia
Independent Director
Jai Diwanji
Independent Director
Manish Kejriwal
Independent Director
Rajkumar Baheti
Independent Director

Mutual Fund Holdings

1 funds · bar length = % to NAVBrowse all funds →
dsp1 scheme
DSP Regular Savings Fund
0.00%
₹0 Cr